GST relief on life-saving drugs a boon for patients

Team L&M

After the 56th meeting of the GST Council, the central government has made a big announcement for patients. Finance Minister Nirmala Sitharaman, during a press conference, stated that GST has now been completely removed from 33 life-saving drugs. Earlier, these drugs attracted 12% GST. These include medicines used in the treatment of cancer as well as several other serious and rare diseases. In addition, GST on three other life-saving drugs has been reduced from 5% to zero. Meanwhile, GST on some other medicines has been reduced from 12% to 5%.

Direct Savings for Patients

Experts believe this decision will bring huge relief to patients since the treatment of diseases like cancer is already very expensive. With drug prices expected to fall, the direct financial burden on families will reduce.

Major Support for the Poor and Middle Class

The treatment of cancer and rare diseases often continues for a long time. The monthly cost of medicines can shatter the financial stability of families.

Dr. Durgatosh pandey,  director surgical oncology at Asian Hospital, says, “Every year, millions of new cancer cases are reported in India. Most of these patients belong to poor and middle-class families. With GST removed, medicines will become relatively cheaper, allowing more patients to afford them. This is a historic step in the healthcare sector.”

Relief for Patients with Rare Diseases

This GST relief is not limited to cancer alone but also applies to medicines used for rare genetic disorders and autoimmune diseases. Although the number of such patients is small, their treatment costs are extremely high. Dr. Pratik Patil, Consultant – Oncologist at Jupiter Hospital, Pune, explains, “Medicines for many genetic disorders are so costly that yearly expenses can run into lakhs of rupees. With this decision, families will face less financial burden and timely treatment will be possible. It is a major step toward healthcare equity.”

Easier Access to Medicines

According to experts, this decision will not only reduce the financial strain on patients but will also ensure easier access to medicines. Due to high treatment costs, patients often stop taking medicines on time, which worsens their health. With reduced taxes, this situation is expected to improve.

The government’s move will undoubtedly bring relief to patients and their families. Lower taxes on life-saving drugs will reduce treatment costs and allow more people to get timely access to medicines. For millions battling cancer and rare diseases, this decision will serve as a new ray of hope.